The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Rapid assessment of avoidable blindness-based healthcare costs of diabetic retinopathy in Hungary and its projection for the year 2045
Abstract
Background/aims: The purpose of this study was to estimate the total healthcare cost associated with diabetic retinopathy (DR) in the population aged 18 years and older in Hungary, and its projection for the year 2045. Methods: A cost model was developed based on the standardised rapid assessment of avoidable blindness with the diabetic retinopathy module (RAAB+DRM) methodology and recently reported prevalent-based cost of illness model. Projection for 2045 was made based on the estimation for increasing diabetes mellitus (DM) prevalence of the International Diabetes Federation. Costs were analysed from the perspective of the healthcare system and the patients. Our DR cost model was constructed according to the Scottish DR grading scale and based on the DR severity stadium. Results: The total DR-associated healthcare cost was US$145.8 million in 2016 and will increase to US$169.0 million by 2045. The two major cost drivers were intravitreal antivascular endothelial growth factor injections and vitrectomies in this study (US$126.4 million in 2016 and US$146.5 million in 2045); they amounted to 86.7% of the total treatment cost of DR. The DR-related cost per patient was US$180.5 in Hungary. Conclusions: The cost per patient for treating DR was lower in Hungary than in other countries. Due to the increasing socioeconomic burden of proliferative DR and diabetes-related blindness, it would be important to invest in DR screening, prevention and early treatment. Our new RAAB-based cost of DR model may facilitate comparisons of DR treatment costs across countries.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Costs associated with DMO were described in six studies for Spain (n = 2) [55, 57], Hungary [54], Italy [56], Sweden [52] and the UK [58].”
From The economic impact of retinal diseases for which gene therapy is emerging: a systematic literature review (2025) · cites this paper as [54]
In the citing paper
“Three model-based studies [54, 56, 58] projected costs associated with DMO at the population level (Supplementary Table 3).”
From The economic impact of retinal diseases for which gene therapy is emerging: a systematic literature review (2025) · cites this paper as [54]
In the citing paper
“The Hungarian study also accounted for anti-VEGF injections in their annual cost estimates ($4,487 per patient) [54].”
From The economic impact of retinal diseases for which gene therapy is emerging: a systematic literature review (2025) · cites this paper as [54]
In the citing paper
“Annual direct medical costs ranged from $45 to $613 in NPDR patients and from $441 to $3,031 in PDR patients (Fig. 5 and Supplementary Table 6), suggesting direct medical costs associated with PDR were about 5.8 times higher than those associated with NPDR.”
From The economic impact of retinal diseases for which gene therapy is emerging: a systematic literature review (2025) · cites this paper as [54]
In the citing paper
“Finally, annual direct medical costs associated with NPDR and PDR were estimated at $2.93 million and $34.32 million respectively in Hungary in the model-based study [54] (Supplementary Table 3).”
From The economic impact of retinal diseases for which gene therapy is emerging: a systematic literature review (2025) · cites this paper as [54]
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
International Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,418
Global estimates of the prevalence of diabetes for 2010 and 2030
Shaw, J. E., Sicree, R. A., & Zimmet, P. Z. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.10.007 · Cited by 7,216
Global prevalence and major risk factors of diabetic retinopathy
Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S.-J., Dekker, J. M., Fletcher, A., Grauslund, J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1909 · Cited by 4,985
Global estimates of visual impairment: 2010
Pascolini, D., & Mariotti, S. P. (2012) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2011-300539 · Cited by 3,763
Global magnitude of visual impairment caused by uncorrected refractive errors in 2004
Resnikoff, S. (2008) · Bulletin of the World Health Organization · doi:10.2471/blt.07.041210 · Cited by 1,151
Global healthcare expenditure on diabetes for 2010 and 2030
Zhang, P., Zhang, X., Brown, J., Vistisen, D., Sicree, R., Shaw, J., & Nichols, G. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.01.026 · Cited by 1,145
Leasher, J. L., Bourne, R. R. A., Flaxman, S. R., Jonas, J. B., Keeffe, J., Naidoo, K., Pesudovs, K., Price, H., White, R. A., Wong, T. Y., et al. (2016) · Diabetes Care · doi:10.2337/dc15-2171 · Cited by 651
The English National Screening Programme for diabetic retinopathy 2003–2016
Scanlon, P. H. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-0974-1 · Cited by 440
Rural–urban disparities in the prevalence of diabetes and coronary heart disease
O'Connor, A., & Wellenius, G. (2012) · Public Health · doi:10.1016/j.puhe.2012.05.029 · Cited by 316
Kassenärztliche Bundesvereinigung
(1985) · Oncology Research and Treatment · doi:10.1159/000215622 · Cited by 306
Research works printed but not linked: 3
- Németh, 2011, Burden of disease of blindness among the elderly in Hungary, Lege Artis Med, 21, 641
- Németh, 2005, Causes of blindness in Hungary between 1996 and 2000, Szemészet, 142, 126
- Németh, 2019, Operating telemedicine ophthalmic screening programs and their possibilities in Hungary, Interdiszciplináris Magyar Egészségügy, 18, 46
Cited by
Benhamza, M., Dahlui, M., & Said, M. A. (2024) · BMC Ophthalmology · doi:10.1186/s12886-024-03665-6 · Cited by 32
“…eye exam, US$ 7.4 for an OCT exam (optical coherence tomography), US$ 9.2 for an FA exam (fluorescein angiography), US$ 5.9 for a U/S exam (ultrasound), US$ 7.6 for PRP laser (pan-retinal photocoagulation) per eye, US$ 1086.9 for IVJ (intravitreal injection), and US$ 858.6 for vitrectomy [11].”
BackgroundInfluentialMei, C., Pan, L., Xu, W., Xu, H., Zhang, Y., Li, Z., Dong, B., Ke, X., McAlinden, C., Yang, M., et al. (2021) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2021.130398 · Cited by 27
Norman, G., Mason, T., Dumville, J. C., Bower, P., Wilson, P. M., & Cullum, N. A. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-064345 · Cited by 21
“181 This is particularly the case with the use of web-based or virtual technology in specific stages Open access of studies.”
BackgroundA cukorbetegség szemészeti szövődményeinek modellalapú költségterhe Magyarországon
Tóth, G., Nagy, Z. Z., & Németh, J. (2021) · Orvosi Hetilap · doi:10.1556/650.2021.32031 · Cited by 12
Self-citationRedding, S., Anderson, R., Raman, R., Sivaprasad, S., & Wittenberg, R. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-063390 · Cited by 9
Metadata
- Authors
- Tóth, G., Limburg, H., Szabó, D., Sándor, G. L., Nagy, Z. Z., & Németh, J.
- Affiliations
- Semmelweis University (HU)
- Corresponding author
- Tóth, Gábor
- Venue
- British Journal of Ophthalmology
- Publisher
- BMJ
- Published
- 2020-08-11
- Volume
- 105
- Issue
- 8
- Pages
- 1116-1120
- ISSN
- 0007-1161 (ISSN-L)
- 1468-2079
- OpenAlex
- W3048513703
- Cited by
- 11
- References
- 26
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 4 · 2021: 2
- FWCI
- 1.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- British Journal of Ophthalmology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Semmelweis Egyetem (EFOP-3.6.3-VEKOP-16-2017-00009)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Ophthalmology and Visual Impairment Studies
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Keywords
- diabetic retinopathy, health care costs, economic burden, avoidable blindness, intravitreal anti-VEGF injection, vitrectomy, proliferative diabetic retinopathy, diabetes prevalence, cost per patient
- MeSH terms
- Aged, Blindness, Diabetic Retinopathy, Female, Fluorescein Angiography, Health Surveys, Humans, Hungary, Male, Middle Aged, Ultrasonography, Health Care Costs, Laser Coagulation, Cost of Illness, Models, Economic, Angiogenesis Inhibitors, Tomography, Optical Coherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Rapid assessment of avoidable blindness-based healthcare costs of diabetic retinopathy in Hungary and its projection for the year 2045. https://app.cochat.ai/papers/10.1136/bjophthalmol-2020-316337
- The paper
- Tóth, G., Limburg, H., Szabó, D., Sándor, G. L., Nagy, Z. Z., & Németh, J. (2021). Rapid assessment of avoidable blindness-based healthcare costs of diabetic retinopathy in Hungary and its projection for the year 2045. British Journal of Ophthalmology. https://doi.org/10.1136/bjophthalmol-2020-316337
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.